Description

The new therapeutic modalities and associated manufacturing processes and technologies require a new workforce skillset. Process automation, process intensification, continuous manufacturing, and scale-out versus scale-up are examples of what are becoming new norms in manufacturing. The demand for a trained workforce is challenging many biopharma companies. This session will discuss approaches for meeting these challenges.

Moderator/Speaker(s):

• Antonio Moreira, PhD, Vice Provost, Academic Affairs, University of Maryland, Baltimore County

Speaker(s):

• John Balchunas, Workforce Director, NIMBL
• Manfred Maeder, PhD, Global Head Device Development & Commercialization, Novartis
• Lindsey Silva, PhD, Senior Manager, Microbiology Global QC Technology, Genentech, A Member of the Roche Group